Stereotaxis Inc.'s common shares have been approved to list on the NYSE American, an exchange designed for growing companies.
The St. Louis-based healthcare technology company's common stock will continue trading on OTCQX until market close Sept. 5 and will begin trading on the NYSE American platform under its current symbol STXS on Sept. 6.
